Four of these genes, RGS2, DLGAP1, BCHE and SNORD116-13 exhibited significantly lower expression in the AD LCL cohort compared with healthy controls, whereas DNASE1L3 exhibited higher expression in the latter (Figures 3a–e). This evidence concerns the gene DLGAP1 and Alzheimer disease.